| Total (N=123) | TARD (n=50) | TaTME (n=73) | P-value |
---|---|---|---|---|
TME | Â | Â | Â | 0.896 |
 Complete | 119 (96.7) | 48 (96.0) | 71 (97.3) |  |
 Nearly complete | 4 (3.3) | 2 (4.0) | 2 (2.7) |  |
 Incomplete | 0 (0) | 0 (0) | 0 (0) |  |
CRM | ||||
 Positive, n (%) | 0 (0) | 0 (0) | 0 (0) |  |
 Negative, n (%) | 123 (100) | 50 (100) | 73 (100) |  |
DM | Â | Â | Â | 1.00 |
 Positive, n (%) | 1 (0.8) | 0 (0) | 1 (1.4) |  |
 Negative | 122 (99.2) | 50 (100) | 72 (98.6) |  |
 Distancea mm (range) | 15 (0.5–45) | 20 (3–45) | 15 (0.5–45) | 0.112 |
Final stage, n (%) | Â | Â | Â | 0.874 |
 I | 52 (42.3) | 22 (44.0) | 30 (41.1) |  |
 II | 33 (26.8) | 12 (24.0) | 21 (28.8) |  |
 III | 31 (25.2) | 12 (24.0) | 19 (26.0) |  |
 IV | 2 (1.6) | 1 (2.0) | 1 (1.4) |  |
 pCR | 5 (4.1) | 3 (6.0) | 2 (2.7) |  |